Priska Auf Der Maur
Basel, BS 4031, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tempered signal strength via low-dose MEK inhibition optimizes therapeutic performance of engineered T cells.
Journal: Journal for immunotherapy of cancer
Published: October 14, 2025
Unraveling T-cell Exhaustion: Genetic Screening Meets In Vitro Modeling.
Journal: Cancer research
Published: October 13, 2023
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment.
Journal: Science translational medicine
Published: November 09, 2022
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy.
Journal: Nature communications
Published: October 26, 2022
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer.
Journal: Cell reports. Medicine
Published: August 08, 2022
Feed-forward loops between metastatic cancer cells and their microenvironment-the stage of escalation.
Journal: EMBO molecular medicine
Published: December 13, 2021
Author Correction: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Journal: Nature
Published: November 12, 2021
Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells.
Journal: Journal of mammary gland biology and neoplasia
Published: August 24, 2021
The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.
Journal: EMBO molecular medicine
Published: July 22, 2020
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Journal: Nature
Published: December 16, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026